Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line

FEBS Letters

Volumn 581, Issue 7, 2007, Pages 1435-1440

  Platet, Nadine ^a   Mayol, Jean François ^b   Berger, François ^a   Hérodin, Francis ^b   Wion, Didier ^a  

^a HÔPITAL MICHALLON   (France)

^b CENTRE DE RECHERCHES   (France)

Author keywords

Cancer stem cell; Glioma; Hoechst 33342; Side population

Indexed keywords

DOXORUBICIN; METHOTREXATE; MITOXANTRONE; RNA; TOPOTECAN;

ANIMAL CELL; ARTICLE; CLONOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; GLIOMA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; GLIOMA; PHENOTYPE; RATS;

EID: 33947403202     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.02.071     Document Type: Article

References (27)

1. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
2. Challen G.A., and Little M.H. A side order of stem cells: the SP phenotype. Stem Cells 24 (2006) 3-12
3. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101 (2004) 781-786
4. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14228-14233
5. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., and Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 65 (2005) 6207-6219
6. Seigel G.M., Campbell L.M., Narayan M., and Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol. Vis. 11 (2005) 729-737
7. Grichnik J.M., Burch J.A., Schulteis R.D., Shan S., Liu J., Darrow T.L., Vervaert C.E., and Seigler H.F. Melanoma, a tumor based on a mutant stem cell?. J. Invest. Dermatol. 126 (2006) 142-153
8. Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y.M., and Eberhart C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66 (2006) 7445-7452
9. Haraguchi N., Utsunomiya T., Inoue H., Tanaka F., Mimori K., Barnard G.F., and Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24 (2006) 506-513
10. Chiba T., Kita K., Zheng Y.W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., and Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44 (2006) 240-251
11. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T., and Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc. Natl. Acad. Sci. USA 103 (2006) 11154-11159
12. Wulf G.G., Wang R.Y., Kuehnle I., Weidner D., Marini F., Brenner M.K., Andreeff M., and Goodell M.A. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98 (2001) 1166-1173
13. Clarke M.F. Neurobiology: at the root of brain cancer. Nature 432 (2004) 281-282
14. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161 (1968) 370-371
15. Baudet C., Chevalier G., Chassevent A., Canova C., Filmon R., Larra F., Brachet P., and Wion D. 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. J. Neurosci. Res. 46 (1996) 540-550
16. Galve-Roperh I., Sanchez C., Cortes M.L., del Pulgar T.G., Izquierdo M., and Guzman M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6 (2000) 313-319
17. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001) 1028-1034
18. Dean M., Fojo T., and Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5 (2005) 275-284
19. Montanaro F., Liadaki K., Schienda J., Flint A., Gussoni E., and Kunkel L.M. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp. Cell Res. 298 (2004) 144-154
20. Parker K.K., Norenberg M.D., and Vernadakis A. "Transdifferentiation" of C6 glial cells in culture. Science 208 (1980) 179-181
21. Gubits R.M., Yu H., Casey G., Munell F., and Vitek M.P. Altered genetic response to beta-adrenergic receptor activation in late passage C6 glioma cells. J. Neurosci. Res. 33 (1992) 297-305
22. Goya L., Feng P.T., Aliabadi S., and Timiras P.S. Effect of growth factors on the in vitro growth and differentiation of early and late passage C6 glioma cells. Int. J. Dev. Neurosci. 14 (1996) 409-417
23. Vernadakis A., Kentroti S., Brodie C., Mangoura D., and Sakellaridis N. C-6 glioma cells of early passage have progenitor properties in culture. Adv. Exp. Med. Biol. 296 (1991) 181-195
24. Maltese W.A., and Volpe J.J. Induction of an oligodendroglial enzyme in C-6 glioma cells maintained at high density or in serum-free medium. J. Cell Physiol. 101 (1979) 459-469
25. Kondo T., and Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289 (2000) 1754-1757
26. Benchaouir R., Rameau P., Decraene C., Dreyfus P., Israeli D., Pietu G., Danos O., and Garcia L. Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp. Cell Res. 294 (2004) 254-268
27. Mitsutake N., Iwao A., Nagai K., Namba H., Ohtsuru A., Saenko V., and Yamashita S. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology (2007) (Epub January 18)